Assessing the Time Demands of Cancer
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Study ID
- NCT05708703
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry the smartphone for 28 consecutive days while outside the home; keep smartphone location and motion services active; confirm and correct (if needed) smartphone-detected activities and trips; use the app interface to provide additional information on activities and trips related to cancer treatment tasks; complete daily surveys regarding well-being; and at the end of the 28 day period, complete an online survey.
Key Dates
- Start date
- Nov 13, 2023
- Status verified
- Sep 2025
- Primary completion
- Sep 9, 2024
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 78 participants (actual)
Arms
- Arm: Study cohortIndividuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey
Primary Outcome Measure
Time Spent on Cancer-related Care Tasks at Home [ Time Frame: 28 days ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | - |
| Masonic Cancer Center - University of Minnesota | Minneapolis | Minnesota | 55455 | - |
Find similar trials in Birmingham, AL
By condition
Related Studies
- Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenRecruiting · M.D. Anderson Cancer Center · Miami, Florida
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in TamponsRecruiting · University of Alabama at Birmingham · Birmingham, Alabama